{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:06:44Z","timestamp":1790129204881,"version":"4.0.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T00:00:00Z","timestamp":1520035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00060911"],"award-info":[{"award-number":["00060911"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00016818"],"award-info":[{"award-number":["00016818"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["201234497"],"award-info":[{"award-number":["201234497"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Labex Cortex","award":["ANR-11-LABX-0042"],"award-info":[{"award-number":["ANR-11-LABX-0042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00702-018-1871-7","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T09:46:19Z","timestamp":1520070379000},"page":"1145-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers"],"prefix":"10.1007","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-8586","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Sgambato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9on","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"issue":"3","key":"1871_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of l-DOPA-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16(3):448\u2013458","journal-title":"Mov Disord"},{"key":"1871_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366\u2013375","journal-title":"Trends Neurosci"},{"issue":"4","key":"1871_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00004691-199407000-00004","volume":"11","author":"GE Alexander","year":"1994","unstructured":"Alexander GE (1994) Basal ganglia-thalamocortical circuits: their role in control of movements. J Clin Neurophysiol 11(4):420\u2013431","journal-title":"J Clin Neurophysiol"},{"key":"1871_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0952523800003229","volume":"10","author":"JS Baizer","year":"1993","unstructured":"Baizer JS, Desimone R, Ungerleider LG (1993) Comparison of subcortical connections of inferior temporal and posterior parietal cortex in monkeys. Vis Neurosci 10:59\u201372","journal-title":"Vis Neurosci"},{"key":"1871_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/archneurol.2010.35","volume":"67","author":"B Ballanger","year":"2010","unstructured":"Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, Fox SH (2010) Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 67:416\u2013421","journal-title":"Arch Neurol"},{"issue":"5","key":"1871_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1523\/JNEUROSCI.2010-15.2016","volume":"36","author":"B Ballanger","year":"2016","unstructured":"Ballanger B, Beaudoin-Gobert M, Neumane S, Epinat J, Metereau E, Duperrier S, Broussolle E, Thobois S, Bonnefoi F, Tourvielle C, Lavenne F, Costes N, Lebars D, Zimmer L, Sgambato-Faure V, Tremblay L (2016) Imaging dopamine and serotonin systems on MPTP monkeys: a longitudinal pet investigation of compensatory mechanisms. J Neurosci 36(5):1577\u20131589","journal-title":"J Neurosci"},{"key":"1871_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerd\u00e8re P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, B\u00e9zard E (2015) Pathophysiology of l-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168","journal-title":"Prog Neurobiol"},{"key":"1871_CR8","first-page":"240","volume":"94","author":"G Battaglia","year":"1989","unstructured":"Battaglia G, De Souza EB (1989) Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems. NIDA Res Monogr 94:240\u2013258","journal-title":"NIDA Res Monogr"},{"key":"1871_CR9","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/brain\/awv183","volume":"138","author":"M Beaudoin-Gobert","year":"2015","unstructured":"Beaudoin-Gobert M, Epinat J, Metereau E, Duperrier S, Neumane S, Ballanger B, Lavenne F, Liger F, Tourvielle C, Bonnefoi F, Costes N, Bars D, Broussolle E, Thobois S, Tremblay L, Sgambato-Faure V (2015) Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain 138:2632\u20132647","journal-title":"Brain"},{"issue":"2","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0006-8993(86)90783-3","volume":"379","author":"PJ B\u00e9dard","year":"1986","unstructured":"B\u00e9dard PJ, Di Paolo T, Falardeau P, Boucher R (1986) Chronic treatment with l-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian mon-keys. Correlation with [3H]spiperone binding. Brain Res 379(2):294\u2013299","journal-title":"Brain Res"},{"issue":"8","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard E, Brotchie JM, Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2(8):577\u2013588","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nm875","volume":"9","author":"E B\u00e9zard","year":"2003","unstructured":"B\u00e9zard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P (2003) Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med 9(6):762\u2013767","journal-title":"Nat Med"},{"key":"1871_CR13","doi-asserted-by":"publisher","first-page":"845618","DOI":"10.1155\/2012\/845618","volume":"2012","author":"J Blesa","year":"2012","unstructured":"Blesa J, Phani S, Jackson-Lewis V, Przedborski S (2012) Classic and new animal models of Parkinson\u2019s disease. J Biomed Biotechnol 2012:845618","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"1871_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02245739","volume":"102","author":"S Boyce","year":"1990","unstructured":"Boyce S, Rupniak NM, Steventon MJ, Iversen SD (1990) Characterisation of dyskinesias induced by l-dopa in MPTP-treated squirrel monkeys. Psychopharmacology 102(1):21\u201327","journal-title":"Psychopharmacology"},{"issue":"1","key":"1871_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0006-8993(97)01158-X","volume":"780","author":"P Burbaud","year":"1998","unstructured":"Burbaud P, Bonnet B, Guehl D, Lagueny A, Bioulac B (1998) Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res 780(1):102\u2013107","journal-title":"Brain Res"},{"issue":"4","key":"1871_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","volume":"64","author":"LH Burns","year":"1995","unstructured":"Burns LH, Pakzaban P, Deacon TW, Brownell AL, Tatter SB, Jenkins BG, Isacson O (1995) Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease. Neuroscience 64(4):1007\u20131017","journal-title":"Neuroscience"},{"key":"1871_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fneur.2014.00078","volume":"5","author":"M Carta","year":"2014","unstructured":"Carta M, Tronci E (2014) Serotonin system implication in l-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78","journal-title":"Front Neurol"},{"key":"1871_CR18","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/awm082","volume":"130","author":"M Carta","year":"2007","unstructured":"Carta M, Carlsson T, Kirik D, Bj\u00f6rklund A (2007) Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819\u20131833","journal-title":"Brain"},{"key":"1871_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fneur.2014.00242","volume":"5","author":"MA Cenci","year":"2014","unstructured":"Cenci MA (2014) Presynaptic mechanisms of l-DOPA induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol 5:242","journal-title":"Front Neurol"},{"issue":"3","key":"1871_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0022-510X(87)90041-4","volume":"78","author":"CE Clarke","year":"1987","unstructured":"Clarke CE, Sambrook MA, Mitchell IJ, Crossman AR (1987) Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci 78(3):273\u2013280","journal-title":"J Neurol Sci"},{"issue":"1","key":"1871_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(87)90322-8","volume":"21","author":"AR Crossman","year":"1987","unstructured":"Crossman AR (1987) Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 21(1):1\u201340","journal-title":"Neuroscience"},{"issue":"3","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0304-3940(80)90176-7","volume":"20","author":"AR Crossman","year":"1980","unstructured":"Crossman AR, Sambrook MA, Jackson A (1980) Experimental hemiballismus in the baboon produced by injection of a gamma-aminobutyric acid antagonist into the basal ganglia. Neurosci Lett 20(3):369\u2013372","journal-title":"Neurosci Lett"},{"issue":"Pt 2","key":"1871_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/brain\/107.2.579","volume":"107","author":"AR Crossman","year":"1984","unstructured":"Crossman AR, Sambrook MA, Jackson A (1984) Experimental hemichorea\/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug induced dyskinesia. Brain 107(Pt 2):579\u2013596","journal-title":"Brain"},{"issue":"Pt 5","key":"1871_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/brain\/111.5.1211","volume":"111","author":"AR Crossman","year":"1988","unstructured":"Crossman AR, Mitchell IJ, Sambrook MA, Jackson A (1988) Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea. Brain 111(Pt 5):1211\u20131233","journal-title":"Brain"},{"key":"1871_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1749-6632.1990.tb16918.x","volume":"600","author":"EB Souza De","year":"1990","unstructured":"De Souza EB, Battaglia G, Insel TR (1990) Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies. Ann N Y Acad Sci 600:682\u2013697 (discussion 697\u2013688)","journal-title":"Ann N Y Acad Sci"},{"key":"1871_CR26","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/brain\/awn255","volume":"131","author":"MM Win de","year":"2008","unstructured":"de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W (2008) Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131:2936\u20132945","journal-title":"Brain"},{"issue":"7","key":"1871_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","volume":"13","author":"MR DeLong","year":"1990","unstructured":"DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281\u2013285","journal-title":"Trends Neurosci"},{"key":"1871_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3","volume":"15","author":"DA Monte Di","year":"2000","unstructured":"Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ (2000) Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord 15:459\u2013466","journal-title":"Mov Disord"},{"key":"1871_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","volume":"20","author":"NJ Diederich","year":"2005","unstructured":"Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson\u2019s disease as disturbed external\/internal perceptions: focused review and a new integrative model. Mov Disord 20:130\u2013140","journal-title":"Mov Disord"},{"issue":"1","key":"1871_CR30","first-page":"13","volume":"8","author":"A Elbaz","year":"2004","unstructured":"Elbaz A, Damier P (2004) Epidemiology of Parkinson\u2019s disease. La letter du Neurologue 8(1):13\u201315 (French)","journal-title":"La letter du Neurologue"},{"key":"1871_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/syn.20630","volume":"63","author":"KL Eskow","year":"2009","unstructured":"Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C (2009) The role of the dorsal raphe nucleus in the development, expression, and treatment of l-dopa-induced dyskinesia in hemiparkinsonian rats. Synapse 63:610\u2013620","journal-title":"Synapse"},{"issue":"1","key":"1871_CR32","first-page":"152","volume":"547","author":"M Filion","year":"1991","unstructured":"Filion M, Tremblay L, B\u00e9dard PJ (1991) Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547(1):152\u2013161","journal-title":"Brain Res"},{"key":"1871_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","volume":"184","author":"SH Fox","year":"2010","unstructured":"Fox SH, Brotchie JM (2010) The MPTP-lesioned non-human primate models of Parkinson\u2019s disease. Past, present, and future. Prog Brain Res 184:133\u2013157 (Review)","journal-title":"Prog Brain Res"},{"key":"1871_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0079-6123(08)00923-0","volume":"172","author":"SH Fox","year":"2008","unstructured":"Fox SH, Chuang R, Brotchie JM (2008) Parkinson\u2019s disease\u2014opportunities for novel therapeutics to reduce the problems of levodopa therapy. Prog Brain Res 172:479\u2013494","journal-title":"Prog Brain Res"},{"key":"1871_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/S0317167100009707","volume":"37","author":"SH Fox","year":"2010","unstructured":"Fox SH, Visanji N, Reyes G, Huot P, Gomez-Ramirez J, Johnston T, Brotchie JM (2010) Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson\u2019s disease. Can J Neurol Sci 37:86\u201395","journal-title":"Can J Neurol Sci"},{"key":"1871_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/mds.25133","volume":"2","author":"SH Fox","year":"2012","unstructured":"Fox SH, Johnston TH, Li Q, Brotchie J, Bezard E (2012) A critique of available scales and presentation of the non-human primate dyskinesia rating scale. Mov Disord 2:1373\u20131378","journal-title":"Mov Disord"},{"issue":"Pt 9","key":"1871_CR37","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/brain\/awh239","volume":"127","author":"C Fran\u00e7ois","year":"2004","unstructured":"Fran\u00e7ois C, Grabli D, McCairn K, Jan C, Karachi C, Hirsch EC, F\u00e9ger J, Tremblay L (2004) Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. Brain 127(Pt 9):2055\u20132070","journal-title":"Brain"},{"key":"1871_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.neuroimage.2016.10.039","volume":"146","author":"L Galineau","year":"2017","unstructured":"Galineau L, Kas A, Worbe Y, Chaigneau M, Herard AS, Guillermier M, Delzescaux T, F\u00e9ger J, Hantraye P, Tremblay L (2017) Cortical areas involved in behavioral expression of external pallidum dysfunctions: a PET imaging study in non-human primates. Neuroimage 146:1025\u20131037","journal-title":"Neuroimage"},{"issue":"4986","key":"1871_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250(4986):1429\u20131432","journal-title":"Science"},{"key":"1871_CR40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ana.22423","volume":"69","author":"MD Gottwald","year":"2011","unstructured":"Gottwald MD, Aminoff MJ (2011) Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Ann Neurol 69:919\u2013927","journal-title":"Ann Neurol"},{"key":"1871_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0091-3057(91)90137-Q","volume":"39","author":"B Gough","year":"1991","unstructured":"Gough B, Ali SF, Slikker W Jr, Holson RR (1991) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav 39:619\u2013623","journal-title":"Pharmacol Biochem Behav"},{"issue":"Pt 9","key":"1871_CR42","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/brain\/awh220","volume":"127","author":"D Grabli","year":"2004","unstructured":"Grabli D, McCairn K, Hirsch EC, Agid Y, F\u00e9ger J, Fran\u00e7ois C, Tremblay L (2004) Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 127(Pt 9):2039\u20132054","journal-title":"Brain"},{"issue":"6","key":"1871_CR43","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","volume":"15","author":"AM Graybiel","year":"2005","unstructured":"Graybiel AM (2005) The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15(6):638\u2013644","journal-title":"Curr Opin Neurobiol"},{"issue":"11","key":"1871_CR44","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1046\/j.1460-9568.2003.02685.x","volume":"17","author":"D Guehl","year":"2003","unstructured":"Guehl D, Pessiglione M, Fran\u00e7ois C, Yelnik J, Hirsch EC, F\u00e9ger J, Tremblay L (2003) Tremor-related activity of neurons in the \u2018motor\u2019 thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism. Eur J Neurosci 17(11):2388\u20132400","journal-title":"Eur J Neurosci"},{"key":"1871_CR45","first-page":"943159","volume":"2012","author":"J Guridi","year":"2012","unstructured":"Guridi J, Gonz\u00e1lez-Redondo R, Obeso JA (2012) Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson\u2019s disease. Parkinsons Dis 2012:943159","journal-title":"Parkinsons Dis"},{"issue":"2","key":"1871_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","volume":"108","author":"P Hantraye","year":"1990","unstructured":"Hantraye P, Riche D, Maziere M, Isacson O (1990) A primate model of Huntington\u2019s disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp Neurol 108(2):91\u2013104","journal-title":"Exp Neurol"},{"key":"1871_CR47","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","volume":"19","author":"G Hatzidimitriou","year":"1999","unstructured":"Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (\u00b1)3,4-methylenedioxymethamphetamine 7\u00a0years previously: factors influencing abnormal recovery. J Neurosci 19:5096\u20135107","journal-title":"J Neurosci"},{"key":"1871_CR48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/mds.23083","volume":"25","author":"P Huot","year":"2010","unstructured":"Huot P, Johnston TH, Darr T, Hazrati LN, Visanji NP, Pires D, Brotchie JM, Fox SH (2010) Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations. Mov Disord 25:1399\u20131408","journal-title":"Mov Disord"},{"key":"1871_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","volume":"95","author":"P Huot","year":"2011","unstructured":"Huot P, Fox SH, Brotchie JM (2011) The serotonergic system in Parkinson\u2019s disease. Prog Neurobiol 95:163\u2013212","journal-title":"Prog Neurobiol"},{"key":"1871_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-0270(99)00184-3","volume":"96","author":"C Imbert","year":"2000","unstructured":"Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE (2000) Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods 96:71\u201376","journal-title":"J Neurosci Methods"},{"key":"1871_CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)23487-5","volume":"249","author":"TR Insel","year":"1989","unstructured":"Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB (1989) 3,4-Methylenedioxymethamphetamine (\u201cecstasy\u201d) selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 249:713\u2013720","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1871_CR52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1460-9568.2005.03915.x","volume":"21","author":"MM Iravani","year":"2005","unstructured":"Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P (2005) A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 21(4):841\u2013854","journal-title":"Eur J Neurosci"},{"issue":"7","key":"1871_CR53","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1046\/j.1460-9568.2003.02946.x","volume":"18","author":"C Jan","year":"2003","unstructured":"Jan C, Pessiglione M, Tremblay L, Tand\u00e9 D, Hirsch EC, Fran\u00e7ois C (2003) Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys. Eur J Neurosci 18(7):2082\u20132086","journal-title":"Eur J Neurosci"},{"issue":"(6) Suppl. 3","key":"1871_CR54","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.61.6_suppl_3.S4","volume":"61","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications. Neurology 61((6) Suppl. 3):S4\u2013S11","journal-title":"Neurology"},{"issue":"8","key":"1871_CR55","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/mds.22547","volume":"24","author":"C Karachi","year":"2009","unstructured":"Karachi C, Grabli D, Baup N, Mounayar S, Tand\u00e9 D, Fran\u00e7ois C, Hirsch EC (2009) Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys. Mov Disord 24(8):1183\u20131192","journal-title":"Mov Disord"},{"key":"1871_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lfs.2014.02.010","volume":"101","author":"SS Karuppagounder","year":"2014","unstructured":"Karuppagounder SS, Bhattacharya D, Ahuja M, Suppiramaniam V, Deruiter J, Clark R, Dhanasekaran M (2014) Elucidating the neurotoxic effects of MDMA and its analogs. Life Sci 101:37\u201342","journal-title":"Life Sci"},{"issue":"Pt 7","key":"1871_CR57","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/brain\/awv134","volume":"138","author":"HF Kim","year":"2015","unstructured":"Kim HF, Hikosaka O (2015) Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards. Brain 138(Pt 7):1776\u20131800","journal-title":"Brain"},{"key":"1871_CR58","first-page":"369","volume-title":"Recent breakthroughs in Basal Ganglia Research","author":"AJ Manson","year":"2006","unstructured":"Manson AJ, Schrag A (2006) Levodopa-induced dyskinesias, the clinical problem: clinical features, incidence, risk factors, management and impact on quality of life. In: Bezard E (ed) Recent breakthroughs in Basal Ganglia Research. Nova Science Publishers Inc., New York, pp 369\u2013380"},{"key":"1871_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0306-4522(94)00484-M","volume":"65","author":"M Matsumura","year":"1995","unstructured":"Matsumura M, Tremblay L, Richard H, Filion M (1995) Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 65:59\u201370","journal-title":"Neuroscience"},{"issue":"3","key":"1871_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/MN:28:3:209","volume":"28","author":"W Meissner","year":"2003","unstructured":"Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, Bezard E (2003) Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson\u2019s disease. Mol Neurobiol 28(3):209\u2013218","journal-title":"Mol Neurobiol"},{"key":"1871_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27201","author":"E M\u00e9t\u00e9reau","year":"2017","unstructured":"M\u00e9t\u00e9reau E, Beaudoin-Gobert M, Duperrier S, Thobois S, Tremblay L, Sgambato-Faure V (2017) Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27201 (Epub ahead of print)","journal-title":"Mov Disord"},{"key":"1871_CR62","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1073\/pnas.93.16.8683","volume":"93","author":"FA Middleton","year":"1996","unstructured":"Middleton FA, Strick PL (1996) The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci USA 93:8683\u20138687","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1871_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/brcg.1999.1099","volume":"42","author":"FA Middleton","year":"2000","unstructured":"Middleton FA, Strick PL (2000) Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42(2):183\u2013200 (Review)","journal-title":"Brain Cogn"},{"issue":"4","key":"1871_CR64","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0301-0082(96)00042-1","volume":"50","author":"JW Mink","year":"1996","unstructured":"Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50(4):381\u2013425 (Review)","journal-title":"Prog Neurobiol"},{"issue":"9","key":"1871_CR65","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1073\/pnas.89.9.3859","volume":"89","author":"R Moratalla","year":"1992","unstructured":"Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM (1992) Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 89(9):3859\u20133863","journal-title":"Proc Natl Acad Sci USA"},{"key":"1871_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1722-y","author":"M Morissette","year":"2017","unstructured":"Morissette M, Di Paolo T (2017) Non-human primate models of PD to test novel therapies. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-017-1722-y","journal-title":"J Neural Transm (Vienna)"},{"key":"1871_CR67","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/brain\/awm208","volume":"130","author":"S Mounayar","year":"2007","unstructured":"Mounayar S, Boulet S, Tande D, Jan C, Pessiglione M, Hirsch EC, Feger J, Savasta M, Francois C, Tremblay L (2007) A new model to study compensatory mechanisms in MPTP treated monkeys exhibiting recovery. Brain 130:2898\u20132914","journal-title":"Brain"},{"key":"1871_CR68","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/awn235","volume":"131","author":"A Munoz","year":"2008","unstructured":"Munoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Bjorklund A, Bezard E, Carta M (2008) Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia. Brain 131:3380\u20133394","journal-title":"Brain"},{"key":"1871_CR69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0079-6123(03)43043-4","volume":"143","author":"A Nambu","year":"2004","unstructured":"Nambu A (2004) A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res 143:461\u2013466 (Review)","journal-title":"Prog Brain Res"},{"key":"1871_CR70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12035-011-8230-0","volume":"45","author":"S Navailles","year":"2012","unstructured":"Navailles S, De Deurwaerd\u00e8re P (2012) Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson\u2019s disease. Mol Neurobiol 45:173\u2013185","journal-title":"Mol Neurobiol"},{"key":"1871_CR71","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","volume":"23","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson\u2019s disease. Trends Neurosci 23:S2\u2013S7","journal-title":"Trends Neurosci"},{"key":"1871_CR72","first-page":"51","volume":"17","author":"JA Obeso","year":"2002","unstructured":"Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Arbizu J, Gimenez-Amaya JM (2002) The basal ganglia and disorders of movement: pathophysiological mechanisms. News Physiol Sci 17:51\u201355","journal-title":"News Physiol Sci"},{"issue":"9942","key":"1871_CR73","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(13)62418-6","volume":"384","author":"JA Obeso","year":"2014","unstructured":"Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ (2014) The expanding universe of disorders of the basal ganglia. Lancet 384(9942):523\u2013531","journal-title":"Lancet"},{"issue":"8","key":"1871_CR74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","volume":"5","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, Obeso JA, Stocchi F (2006) Continuous dopamine-receptor treatment of Parkinson\u2019s disease: scientific rationale and clinical implications. Lancet Neurol 5(8):677\u2013687","journal-title":"Lancet Neurol"},{"key":"1871_CR75","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20:128\u2013154","journal-title":"Brain Res Rev"},{"issue":"2","key":"1871_CR76","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.0953-816X.2003.03088.x","volume":"19","author":"M Pessiglione","year":"2004","unstructured":"Pessiglione M, Guehl D, Hirsch EC, F\u00e9ger J, Tremblay L (2004) Disruption of self-organized actions in monkeys with progressive MPTP-induced Parkinsonism. I. Effects of task complexity. Eur J Neurosci 19(2):426\u2013436","journal-title":"Eur J Neurosci"},{"key":"1871_CR77","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","volume":"10","author":"M Politis","year":"2014","unstructured":"Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10:708\u2013722","journal-title":"Nat Rev Neurol"},{"key":"1871_CR78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis M, Niccolini F (2015) Serotonin in Parkinson\u2019s disease. Behav Brain Res 277:136\u2013145","journal-title":"Behav Brain Res"},{"key":"1871_CR79","doi-asserted-by":"publisher","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","volume":"2","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants. Sci Transl Med 2:38ra46","journal-title":"Sci Transl Med"},{"key":"1871_CR80","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/mds.23743","volume":"26","author":"M Politis","year":"2011","unstructured":"Politis M, Oertel WH, Wu K, Quinn NP, Pogarell O, Brooks DJ et al (2011) Graft-induced dyskinesias in Parkinson\u2019s disease: high striatal serotonin\/dopamine transporter ratio. Mov Disord 26:1997\u20132003","journal-title":"Mov Disord"},{"key":"1871_CR81","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1172\/JCI71640","volume":"124","author":"M Politis","year":"2014","unstructured":"Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P et al (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients. J Clin Investig 124:1340\u20131349","journal-title":"J Clin Investig"},{"key":"1871_CR82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2013.09.014","volume":"256","author":"LF Potts","year":"2014","unstructured":"Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM (2014) Modeling Parkinson\u2019s disease in monkeys for translational studies, a critical analysis. Exp Neurol 256:133\u2013143","journal-title":"Exp Neurol"},{"issue":"Suppl. 3","key":"1871_CR83","first-page":"S12","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL (2003) Limitations of current Parkinson\u2019s disease therapy. Ann Neurol 53(Suppl. 3):S12\u2013S15 (S3\u201312 discussion)","journal-title":"Ann Neurol"},{"key":"1871_CR84","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.1988.03410010059035","volume":"260","author":"GA Ricaurte","year":"1988","unstructured":"Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW (1988) (\u00b1)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260:51\u201355","journal-title":"JAMA"},{"key":"1871_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000026664","volume":"42","author":"GA Ricaurte","year":"2000","unstructured":"Ricaurte GA, Yuan J, McCann UD (2000) (\u00b1)3,4-Methylenedioxymethamphetamine (\u2018Ecstasy\u2019)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5\u201310","journal-title":"Neuropsychobiology"},{"issue":"12","key":"1871_CR86","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1212\/WNL.0000000000002494","volume":"86","author":"AA Roussakis","year":"2016","unstructured":"Roussakis AA, Politis M, Towey D, Piccini P (2016) Serotonin-to-dopamine transporter ratios in Parkinson disease: relevance for dyskinesias. Neurology 86(12):1152\u20131158","journal-title":"Neurology"},{"key":"1871_CR87","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","volume":"89","author":"G Rudnick","year":"1992","unstructured":"Rudnick G, Wall SC (1992) The molecular mechanism of \u201cecstasy\u201d [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817\u20131821","journal-title":"Proc Natl Acad Sci USA"},{"key":"1871_CR88","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/ana.22097","volume":"68","author":"D Rylander","year":"2010","unstructured":"Rylander D, Parent M, O\u2019Sullivan SS, Dovero S, Lees AJ, B\u00e9zard E et al (2010) Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 68:619\u2013628","journal-title":"Ann Neurol"},{"issue":"4","key":"1871_CR89","first-page":"2528","volume":"27","author":"Y Saga","year":"2017","unstructured":"Saga Y, Richard A, Sgambato-Faure V, Hoshi E, Tobler PN, Tremblay L (2017) Ventral pallidum encodes contextual information and controls aversive behaviors. Cereb Cortex 27(4):2528\u20132543","journal-title":"Cereb Cortex"},{"issue":"1","key":"1871_CR90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0091-3057(89)90372-9","volume":"34","author":"JS Schneider","year":"1989","unstructured":"Schneider JS (1989) Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage. Pharmacol Biochem Behav 34(1):193\u2013196","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"1871_CR91","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/1055-8330(95)90014-4","volume":"4","author":"JS Schneider","year":"1995","unstructured":"Schneider JS, Pope-Coleman A (1995) Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 4(3):245\u2013255","journal-title":"Neurodegeneration"},{"issue":"1","key":"1871_CR92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pneurobio.2011.10.005","volume":"96","author":"V Sgambato-Faure","year":"2012","unstructured":"Sgambato-Faure V, Cenci MA (2012) Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson\u2019s disease. Prog Neurobiol 96(1):69\u201386","journal-title":"Prog Neurobiol"},{"key":"1871_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1693-z","author":"V Sgambato-Faure","year":"2017","unstructured":"Sgambato-Faure V, Tremblay L (2017) Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-017-1693-z ((Epub ahead of print) Review)","journal-title":"J Neural Transm (Vienna)"},{"key":"1871_CR94","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00429-014-0911-9","volume":"221","author":"V Sgambato-Faure","year":"2016","unstructured":"Sgambato-Faure V, Worbe Y, Epinat J, Feger J, Tremblay L (2016) Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates. Brain Struct Funct 221:345\u2013364","journal-title":"Brain Struct Funct"},{"issue":"4","key":"1871_CR95","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.neurobiolaging.2014.12.037","volume":"36","author":"R Smith","year":"2015","unstructured":"Smith R, Wu K, Hart T, Loane C, Brooks DJ, Bj\u00f6rklund A, Odin P, Piccini P, Politis M (2015) The role of pallidal serotonergic function in Parkinson\u2019s disease dyskinesias: a positron emission tomography study. Neurobiol Aging 36(4):1736\u20131742","journal-title":"Neurobiol Aging"},{"key":"1871_CR96","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1523\/JNEUROSCI.20-13-05102.2000","volume":"20","author":"DD Song","year":"2000","unstructured":"Song DD, Haber SN (2000) Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J Neurosci 20:5102\u20135114","journal-title":"J Neurosci"},{"key":"1871_CR97","first-page":"CD006564","volume":"2","author":"RL Stowe","year":"2008","unstructured":"Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R (2008) Dopamine agonist therapy in early Parkinson\u2019s disease. Cochrane Database Syst Rev 2:CD006564","journal-title":"Cochrane Database Syst Rev"},{"key":"1871_CR98","first-page":"678","volume":"43","author":"Z Szabo","year":"2002","unstructured":"Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA (2002) Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43:678\u2013692","journal-title":"J Nucl Med"},{"key":"1871_CR99","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","volume":"10","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M (1999) Role of serotonergic neurons in l-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 10:631\u2013634","journal-title":"Neuroreport"},{"key":"1871_CR100","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/mds.26199","volume":"30","author":"L Tremblay","year":"2015","unstructured":"Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Feger J (2015) Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 30:1155\u20131170","journal-title":"Mov Disord"},{"key":"1871_CR101","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/mds.21073","volume":"21","author":"NP Visanji","year":"2006","unstructured":"Visanji NP, Gomez-Ramirez J, Johnston TH, Pires D, Voon V, Brotchie JM, Fox SH (2006) Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson\u2019s disease. Mov Disord 21:1879\u20131891","journal-title":"Mov Disord"},{"issue":"3","key":"1871_CR102","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol 16(3):238\u2013250","journal-title":"Lancet Neurol"},{"key":"1871_CR103","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","volume":"4","author":"DR Williams","year":"2005","unstructured":"Williams DR, Lees AJ (2005) Visual hallucinations in the diagnosis of idiopathic Parkinson\u2019s disease: a retrospective autopsy study. Lancet Neurol 4:605\u2013610","journal-title":"Lancet Neurol"},{"issue":"8","key":"1871_CR104","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/cercor\/bhn214","volume":"19","author":"Y Worbe","year":"2009","unstructured":"Worbe Y, Baup N, Grabli N, Chaigneau M, Mounayar S, McCairn K, F\u00e9ger J, Tremblay L (2009) Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cereb Cortex 19(8):1844\u20131856","journal-title":"Cereb Cortex"},{"issue":"12","key":"1871_CR105","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/cercor\/bhr063","volume":"21","author":"Y Worbe","year":"2011","unstructured":"Worbe Y, Epinat J, F\u00e9ger J, Tremblay L (2011) Discontinuous long-train stimulation in the anterior striatum in monkeys induces abnormal behavioral states. Cereb Cortex 21(12):2733\u20132741","journal-title":"Cereb Cortex"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1871-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1871-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1871-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:18:41Z","timestamp":1751447921000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1871-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1871-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]},"assertion":[{"value":"9 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}